- call +1-201-465-4211
- email sales@mrinsights.biz
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Scope of the Report:
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.
Methotrexate is a drug used to treat several forms of cancer as well as some autoimmune system diseases. In 2014, methotrexate for breast, head and neck, lung, stomach, and esophagus cancers occupies more than 70% share of total amount. As the demand increases rapidly with higher spending propensity, the increased consumption is expected to continue during the remaining years of the forecast period of 2016-2021. Methotrexate industry will usher in a stable growth space.
The worldwide market for Methotrexate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Methotrexate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Methotrexate for Injection
Methotrexate Tablets
Market Segment by Applications, can be divided into
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Methotrexate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Methotrexate, with price, sales, revenue and global market share of Methotrexate in 2017 and 2018.
Chapter 3, the Methotrexate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Methotrexate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Methotrexate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Methotrexate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Methotrexate Introduction
1.2 Market Analysis by Type
1.2.1 Methotrexate for Injection
1.2.2 Methotrexate Tablets
1.3 Market Analysis by Applications
1.3.1 Used for Cancers
1.3.2 Used for Rheumatoid Arthritis
1.3.3 Used for Other Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries
2.1.1 Business Overview
2.1.2 Methotrexate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Qualitestrx(DAVA Pharmaceuticals)
2.2.1 Business Overview
2.2.2 Methotrexate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qualitestrx(DAVA Pharmaceuticals) Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer (Hospira)
2.3.1 Business Overview
2.3.2 Methotrexate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer (Hospira) Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roxane Laboratories
2.4.1 Business Overview
2.4.2 Methotrexate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roxane Laboratories Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sine
2.5.1 Business Overview
2.5.2 Methotrexate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sine Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Maoxiang
2.6.1 Business Overview
2.6.2 Methotrexate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Maoxiang Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 LingNan Pharmaceutical
2.7.1 Business Overview
2.7.2 Methotrexate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LingNan Pharmaceutical Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Powerdone
2.8.1 Business Overview
2.8.2 Methotrexate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Powerdone Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Huiyu
2.9.1 Business Overview
2.9.2 Methotrexate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Huiyu Methotrexate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Methotrexate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Methotrexate Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Methotrexate Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Methotrexate Manufacturer Market Share in 2018
3.3.2 Top 6 Methotrexate Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Methotrexate Market Analysis by Regions
4.1 Global Methotrexate Sales, Revenue and Market Share by Regions
4.1.1 Global Methotrexate Sales and Market Share by Regions (2014-2019)
4.1.2 Global Methotrexate Revenue and Market Share by Regions (2014-2019)
4.2 North America Methotrexate Sales and Growth Rate (2014-2019)
4.3 Europe Methotrexate Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Methotrexate Sales and Growth Rate (2014-2019)
4.5 South America Methotrexate Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Methotrexate Sales and Growth Rate (2014-2019)
5 North America Methotrexate by Country
5.1 North America Methotrexate Sales, Revenue and Market Share by Country
5.1.1 North America Methotrexate Sales and Market Share by Country (2014-2019)
5.1.2 North America Methotrexate Revenue and Market Share by Country (2014-2019)
5.2 United States Methotrexate Sales and Growth Rate (2014-2019)
5.3 Canada Methotrexate Sales and Growth Rate (2014-2019)
5.4 Mexico Methotrexate Sales and Growth Rate (2014-2019)
6 Europe Methotrexate by Country
6.1 Europe Methotrexate Sales, Revenue and Market Share by Country
6.1.1 Europe Methotrexate Sales and Market Share by Country (2014-2019)
6.1.2 Europe Methotrexate Revenue and Market Share by Country (2014-2019)
6.2 Germany Methotrexate Sales and Growth Rate (2014-2019)
6.3 UK Methotrexate Sales and Growth Rate (2014-2019)
6.4 France Methotrexate Sales and Growth Rate (2014-2019)
6.5 Russia Methotrexate Sales and Growth Rate (2014-2019)
6.6 Italy Methotrexate Sales and Growth Rate (2014-2019)
7 Asia-Pacific Methotrexate by Country
7.1 Asia-Pacific Methotrexate Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Methotrexate Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Methotrexate Revenue and Market Share by Country (2014-2019)
7.2 China Methotrexate Sales and Growth Rate (2014-2019)
7.3 Japan Methotrexate Sales and Growth Rate (2014-2019)
7.4 Korea Methotrexate Sales and Growth Rate (2014-2019)
7.5 India Methotrexate Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Methotrexate Sales and Growth Rate (2014-2019)
8 South America Methotrexate by Country
8.1 South America Methotrexate Sales, Revenue and Market Share by Country
8.1.1 South America Methotrexate Sales and Market Share by Country (2014-2019)
8.1.2 South America Methotrexate Revenue and Market Share by Country (2014-2019)
8.2 Brazil Methotrexate Sales and Growth Rate (2014-2019)
8.3 Argentina Methotrexate Sales and Growth Rate (2014-2019)
8.4 Colombia Methotrexate Sales and Growth Rate (2014-2019)
9 Middle East and Africa Methotrexate by Countries
9.1 Middle East and Africa Methotrexate Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Methotrexate Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Methotrexate Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Methotrexate Sales and Growth Rate (2014-2019)
9.3 Turkey Methotrexate Sales and Growth Rate (2014-2019)
9.4 Egypt Methotrexate Sales and Growth Rate (2014-2019)
9.5 Nigeria Methotrexate Sales and Growth Rate (2014-2019)
9.6 South Africa Methotrexate Sales and Growth Rate (2014-2019)
10 Global Methotrexate Market Segment by Type
10.1 Global Methotrexate Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Methotrexate Sales and Market Share by Type (2014-2019)
10.1.2 Global Methotrexate Revenue and Market Share by Type (2014-2019)
10.2 Methotrexate for Injection Sales Growth and Price
10.2.1 Global Methotrexate for Injection Sales Growth (2014-2019)
10.2.2 Global Methotrexate for Injection Price (2014-2019)
10.3 Methotrexate Tablets Sales Growth and Price
10.3.1 Global Methotrexate Tablets Sales Growth (2014-2019)
10.3.2 Global Methotrexate Tablets Price (2014-2019)
11 Global Methotrexate Market Segment by Application
11.1 Global Methotrexate Sales Market Share by Application (2014-2019)
11.2 Used for Cancers Sales Growth (2014-2019)
11.3 Used for Rheumatoid Arthritis Sales Growth (2014-2019)
11.4 Used for Other Diseases Sales Growth (2014-2019)
12 Methotrexate Market Forecast (2019-2024)
12.1 Global Methotrexate Sales, Revenue and Growth Rate (2019-2024)
12.2 Methotrexate Market Forecast by Regions (2019-2024)
12.2.1 North America Methotrexate Market Forecast (2019-2024)
12.2.2 Europe Methotrexate Market Forecast (2019-2024)
12.2.3 Asia-Pacific Methotrexate Market Forecast (2019-2024)
12.2.4 South America Methotrexate Market Forecast (2019-2024)
12.2.5 Middle East and Africa Methotrexate Market Forecast (2019-2024)
12.3 Methotrexate Market Forecast by Type (2019-2024)
12.3.1 Global Methotrexate Sales Forecast by Type (2019-2024)
12.3.2 Global Methotrexate Market Share Forecast by Type (2019-2024)
12.4 Methotrexate Market Forecast by Application (2019-2024)
12.4.1 Global Methotrexate Sales Forecast by Application (2019-2024)
12.4.2 Global Methotrexate Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Methotrexate Picture
Table Product Specifications of Methotrexate
Figure Global Sales Market Share of Methotrexate by Types in 2018
Table Methotrexate T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
